|
2024
|
Invention
|
Inhibitors of smndc1 and their therapeutic use. The present invention provides novel SMNDC1 inhib... |
|
|
Invention
|
Bifunctional protein targeting chimeras (protacs) comprising arylidene-indolinone scaffold as dca... |
|
2023
|
Invention
|
Method for optimizing t cells for immuno-therapy. in vitro in vivo inviroviro, e.g., for adoptive... |
|
|
Invention
|
Tasl mimicking molecules and applications thereof. The present invention relates to a compound of... |
|
2022
|
Invention
|
Method for improved intron tagging and automated clone recognition. The present invention relates... |
|
|
Invention
|
1,2,4-triazolo[1,5-a]pyrimidine-based slc16a3 inhibitors and their therapeutic use.
The present ... |
|
|
Invention
|
1,2,4-triazolo[1,5-a]pyrimidine-based slc16a3 inhibitors and their therapeutic use. The present i... |
|
|
Invention
|
3-(phthalazin-1-yl)benzenesulfonamide-based slc16a3 inhibitors and their therapeutic use. The pre... |
|
|
Invention
|
Mutant calreticulin for the diagnosis of myeloid malignancies.
The present invention relates to ... |
|
2021
|
Invention
|
Anti-april antibodies and uses thereof.
The present invention relates to an antibody, or an anti... |
|
|
Invention
|
Anti-april antibodies and uses thereof. The present invention relates to an antibody, or an antig... |
|
|
Invention
|
Heterocyclic cullin ring ubiquitin ligase compounds and uses thereof. The present invention relat... |
|
|
Invention
|
Computer-implemented method for semi-automatic segmentation of medical imaging data and interacti... |
|
2020
|
Invention
|
Novel method for pooled intron tagging for real time drug screening.
The present invention relat... |
|
|
Invention
|
Novel method for pooled intron tagging for real time drug screening. The present invention relate... |
|
|
Invention
|
Compounds for targeted degradation of carrier proteins and uses thereof.
The present invention r... |
|
|
Invention
|
Carbazole-type cullin ring ubiquitin ligase compounds and uses thereof. The present invention rel... |
|
|
Invention
|
Compounds for targeted degradation of carrier proteins and uses thereof. The present invention re... |
|
|
Invention
|
Oxazole and thioazole-type cullin ring ubiquitin ligase compounds and uses thereof. The present i... |
|
|
P/S
|
Data networks; Virtual reality software for education; Virtual reality software; Artificial intel... |
|
|
Invention
|
Method for sequencing rna oligonucleotides.
The invention relates to a method for sequencing oli... |
|
|
Invention
|
Method for sequencing rna oligonucleotides. The invention relates to a method for sequencing olig... |
|
2019
|
P/S
|
Chemical preparations for use in RNA analysis and/or DNA analysis [other than medical]; Reagents ... |
|
|
Invention
|
Method for identifying a chemical compound or agent inducing ubiquitination of a protein of inter... |
|
|
Invention
|
Mutant calreticulin for the diagnosis of myeloid malignancies. The present invention relates to a... |
|
2018
|
Invention
|
Methods for determining selectivity of test compounds. The invention relates to methods for deter... |
|
|
Invention
|
Sulfonylurea compounds in the treatment of disease associated with uv-induced damage.
The presen... |
|
|
Invention
|
Sulfonylurea compounds in the treatment of disease associated with uv-induced damage. The present... |
|
|
Invention
|
Methods for determining interaction between biological cells. The present invention relates to me... |
|
2017
|
Invention
|
Combination of a brd4 inhibitor and an antifolate for the therapy of cancer.
The present inventi... |
|
|
Invention
|
Combination of a brd4 inhibitor and an antifolate for the therapy of cancer. The present inventio... |
|
|
P/S
|
Chemical preparations for use in medical diagnostics, in particular preparations for personalised... |
|
|
Invention
|
Multiwell imaging plate and method for incubating non-adherent cells. The invention relates to a ... |
|
|
Invention
|
Taf1 inhibitors for the therapy of cancer. The present invention relates to lactam derivatives of... |
|
2016
|
Invention
|
Ros1 positive cancer treatment. ROS1 inhibitor for use in the treatment of a subject suffering fr... |
|
|
Invention
|
Methods for studying nucleic acids. The present invention provides a novel method for preparing a... |
|
|
Invention
|
Combination of an antiandrogen with a vitamin k antagonist or with a gamma-glutamyl carboxylase i... |
|
|
Invention
|
Combination of an antiandrogen with a vitamin k antagonist or with a gamma -glutamyl carboxylase ... |
|
|
Invention
|
Substituted 4-(phenylamino)quinoline derivatives as mth1 inhibitors for the therapy of cancer. Th... |
|
|
Invention
|
Oxoquinoline derivatives as mth1 inhibitors for the therapy of cancer. The present invention rela... |
|
|
P/S
|
[ Treatment of nucleic acids, proteins and chromatin; treatment of nucleic acids with enzymatic r... |
|
|
P/S
|
Chemical preparations for use in DNA analysis [other than
medical]; reagents for use in scientif... |
|
2015
|
P/S
|
Chemical preparations for use in DNA analysis [other than medical]; Reagents for use in scientifi... |
|
|
Invention
|
Medical use of artemisinin compounds and gephyrin agonists. The invention refers to BTBD9 binders... |
|
2014
|
P/S
|
Biochemical or chemical products for use in industry and science; biochemicals or chemical reagen... |
|
2013
|
P/S
|
Chemical, biochemical and biological products used in industry and science; in-vitro diagnostic p... |
